cells therapy Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (12)

Phase 1 (3)
Phase 1/2 (7)
Phase 3 (1)
Unknown (1)

Interventional (12)

Chongqing Precision Biotech Co., Ltd (4)
Shenzhen Geno-Immune Medical Institute (2)
Autolus Limited (1)
Fred Hutchinson Cancer Research Center (1)
He Huang (1)
Shanghai Cell Therapy Group Co.,Ltd (1)
The First Affiliated Hospital of Soochow University (1)
Uppsala University (1)

No (11)
Yes (1)

No (12)

Adult (18+) (12)
Pediatric (Under 18) (6)

I am/have/had

I am/have/hadPCR test

I am/have/hadacute respiratory distress

I am/have/hadchronic lymphocytic leukemia

I am/have/hadmental disorders

I am/have/hadrenal function

I am/have/hadchemotherapy regimen

I am/have/hadmultiple myeloma

I am/have/hadrefractory multiple myeloma

I am/have/hadacute myeloid leukemia

I am/have/hadcell therapy

I am/have/hadt cell therapy

I am/have/hadleukemia

I am/have/hadcoronavirus infection

I am/have/hadcoronavirus

I am/have/hadalt/ast

I am/have/hadlymphoma

I am/have/hadmental illness

I am/have/hadstem cell transplantation

I am/have/hadcellular therapy

I am/have/hadplatelet count

added new label for I am/have/had

more

I am looking for

I am looking forinactivated rabies virus vaccine

I am looking fordexamethasone

I am looking forclarithromycin

I am looking forlenalidomide

I am looking forbcma

added new label for I am looking for

more

Advanced Filters

Loading...

Found 12 clinical trials

For pediatric ages
For Seniors
Recruiting in 100s
Interventional Study
all
Recruiting

A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies

A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies.

0 views
19 Feb, 2024
1 location

Phase 3
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

The purpose of this study is to evaluate the safety and efficacy of BiRd regimen combined with BCMA CAR T cell therapy in newly diagnosed multiple myeloma patients

cellular therapy

clarithromycin

car t-cell therapy

lenalidomide

ejection fraction

0 views
19 Feb, 2024
1 location

1
2

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.